Matthews DR - Search Results

1

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.

Schernthaner G, Matthews DR, Charbonnel B, Hanefeld M, Brunetti P; Quartet [corrected] Study Group. Schernthaner G, et al. Among authors: matthews dr. J Clin Endocrinol Metab. 2004 Dec;89(12):6068-76. doi: 10.1210/jc.2003-030861. J Clin Endocrinol Metab. 2004. PMID: 15579760 Clinical Trial.

2

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.

Matthews DR, Charbonnel BH, Hanefeld M, Brunetti P, Schernthaner G. Matthews DR, et al. Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):167-74. doi: 10.1002/dmrr.478. Diabetes Metab Res Rev. 2005. PMID: 15386821 Clinical Trial.

3

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.

Charbonnel BH, Matthews DR, Schernthaner G, Hanefeld M, Brunetti P; QUARTET Study Group. Charbonnel BH, et al. Among authors: matthews dr. Diabet Med. 2005 Apr;22(4):399-405. doi: 10.1111/j.1464-5491.2004.01426.x. Diabet Med. 2005. PMID: 15787663 Clinical Trial.

4

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.

Charbonnel B, Schernthaner G, Brunetti P, Matthews DR, Urquhart R, Tan MH, Hanefeld M. Charbonnel B, et al. Among authors: matthews dr. Diabetologia. 2005 Jun;48(6):1093-104. doi: 10.1007/s00125-005-1751-1. Epub 2005 May 12. Diabetologia. 2005. PMID: 15889234 Free article. Clinical Trial.

5

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, Arima H, Monaghan H, Joshi R, Colagiuri S, Cooper ME, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Lisheng L, Mancia G, Marre M, Matthews DR, Mogensen CE, Perkovic V, Poulter N, Rodgers A, Williams B, MacMahon S, Patel A, Woodward M; ADVANCE-ON Collaborative Group. Zoungas S, et al. Among authors: matthews dr. N Engl J Med. 2014 Oct 9;371(15):1392-406. doi: 10.1056/NEJMoa1407963. Epub 2014 Sep 19. N Engl J Med. 2014. PMID: 25234206 Free article. Clinical Trial.

6

The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus.

Cheetham TD, Clayton KL, Taylor AM, Holly J, Matthews DR, Dunger DB. Cheetham TD, et al. Among authors: matthews dr. Clin Endocrinol (Oxf). 1994 Apr;40(4):515-22. doi: 10.1111/j.1365-2265.1994.tb02492.x. Clin Endocrinol (Oxf). 1994. PMID: 8187319 Clinical Trial.

7

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study.

Nauck M, Frid A, Hermansen K, Thomsen AB, During M, Shah N, Tankova T, Mitha I, Matthews DR. Nauck M, et al. Among authors: matthews dr. Diabetes Obes Metab. 2013 Mar;15(3):204-12. doi: 10.1111/dom.12012. Epub 2012 Oct 11. Diabetes Obes Metab. 2013. PMID: 22985213 Review.

8

Lipid profile, glucose tolerance and insulin sensitivity after more than four years of growth hormone therapy in non-growth hormone deficient adolescents.

Bareille P, Azcona C, Matthews DR, Conway GS, Stanhope R. Bareille P, et al. Among authors: matthews dr. Clin Endocrinol (Oxf). 1999 Sep;51(3):347-53. doi: 10.1046/j.1365-2265.1999.00765.x. Clin Endocrinol (Oxf). 1999. PMID: 10469015

9

The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia.

Pal BR, Matthews DR, Edge JA, Mullis PE, Hindmarsh PC, Dunger DB. Pal BR, et al. Among authors: matthews dr. Clin Endocrinol (Oxf). 1993 Jan;38(1):93-100. doi: 10.1111/j.1365-2265.1993.tb00978.x. Clin Endocrinol (Oxf). 1993. PMID: 8435890

10

Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetes.

Hosker JP, Burnett MA, Matthews DR, Turner RC. Hosker JP, et al. Among authors: matthews dr. Metabolism. 1993 Sep;42(9):1116-20. doi: 10.1016/0026-0495(93)90268-s. Metabolism. 1993. PMID: 8412763 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page